Vicus Capital increased its position in Dow Chemical Company (The) (NYSE:DOW) by 13.9% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 14,420 shares of the basic materials company’s stock after buying an additional 1,755 shares during the period. Vicus Capital’s holdings in Dow Chemical Company (The) were worth $909,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently bought and sold shares of the company. Jennison Associates LLC boosted its stake in Dow Chemical Company (The) by 23.1% in the first quarter. Jennison Associates LLC now owns 2,487,443 shares of the basic materials company’s stock valued at $158,052,000 after buying an additional 467,320 shares in the last quarter. Bremer Trust National Association boosted its stake in Dow Chemical Company (The) by 4.9% in the first quarter. Bremer Trust National Association now owns 21,010 shares of the basic materials company’s stock valued at $1,335,000 after buying an additional 983 shares in the last quarter. Grassi Investment Management boosted its stake in Dow Chemical Company (The) by 0.4% in the first quarter. Grassi Investment Management now owns 114,251 shares of the basic materials company’s stock valued at $7,260,000 after buying an additional 401 shares in the last quarter. Boston Advisors LLC boosted its stake in Dow Chemical Company (The) by 0.6% in the first quarter. Boston Advisors LLC now owns 137,814 shares of the basic materials company’s stock valued at $8,757,000 after buying an additional 804 shares in the last quarter. Finally, Bollard Group LLC boosted its stake in Dow Chemical Company (The) by 8.8% in the first quarter. Bollard Group LLC now owns 89,528 shares of the basic materials company’s stock valued at $5,689,000 after buying an additional 7,213 shares in the last quarter. 68.79% of the stock is owned by institutional investors.

Dow Chemical Company (NYSE:DOW) traded up 0.49% during trading on Friday, reaching $63.42. The company had a trading volume of 2,320,196 shares. Dow Chemical Company has a 52-week low of $51.57 and a 52-week high of $67.50. The company has a 50-day moving average of $64.63 and a 200-day moving average of $63.02. The firm has a market capitalization of $77.59 billion, a P/E ratio of 27.16 and a beta of 1.13.

Dow Chemical Company (The) (NYSE:DOW) last posted its quarterly earnings results on Thursday, July 27th. The basic materials company reported $1.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.07. The company had revenue of $13.83 billion for the quarter, compared to analysts’ expectations of $13.60 billion. Dow Chemical Company (The) had a return on equity of 17.08% and a net margin of 5.83%. The firm’s revenue was up 15.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.95 earnings per share. Analysts expect that Dow Chemical Company will post $4.08 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Monday, July 31st will be issued a $0.46 dividend. The ex-dividend date is Thursday, July 27th. This represents a $1.84 annualized dividend and a dividend yield of 2.92%. Dow Chemical Company (The)’s dividend payout ratio is currently 76.99%.

ILLEGAL ACTIVITY NOTICE: This story was published by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://www.watchlistnews.com/vicus-capital-buys-1755-shares-of-dow-chemical-company-the-dow/1475042.html.

Several analysts have recently commented on DOW shares. Zacks Investment Research cut Dow Chemical Company (The) from a “buy” rating to a “hold” rating in a report on Thursday, April 20th. Alembic Global Advisors set a $85.00 price target on Dow Chemical Company (The) and gave the company a “buy” rating in a report on Thursday, July 27th. Citigroup Inc. raised their price target on Dow Chemical Company (The) from $73.00 to $74.00 and gave the company a “buy” rating in a report on Monday, May 1st. Barclays PLC raised their price target on Dow Chemical Company (The) from $65.00 to $67.00 and gave the company an “equal weight” rating in a report on Monday, May 1st. Finally, Royal Bank Of Canada reissued a “buy” rating and issued a $76.00 price target on shares of Dow Chemical Company (The) in a report on Friday, April 28th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $71.42.

About Dow Chemical Company (The)

Want to see what other hedge funds are holding DOW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dow Chemical Company (The) (NYSE:DOW).

Institutional Ownership by Quarter for Dow Chemical Company (The) (NYSE:DOW)

Receive News & Ratings for Dow Chemical Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.